Literature DB >> 5108223

Naloxone treatment of opiate dependence. A progress report.

A Zaks, T Jones, M Fink, A M Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5108223

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Oral naloxone antagonizes loperamide-induced delay of orocecal transit.

Authors:  G Basilisco; G Camboni; A Bozzani; M Paravicini; P A Bianchi
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

Review 3.  The role of naltrexone in the management of drug abuse.

Authors:  H M Ginzburg; M G MacDonald
Journal:  Med Toxicol       Date:  1987 Mar-Apr

4.  Failure of naloxone to modify the depth of hypnotic trance.

Authors:  G Spruiell; C Steck; C K Lippincott; C King
Journal:  Experientia       Date:  1983-07-15

5.  Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.

Authors:  H E Shannon; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1976-11-10       Impact factor: 4.530

6.  Naloxone changes self-ratings but not performance in normal subjects.

Authors:  S E File; T Silverstone
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Metabolic, respiratory, vasomotor and body temperature responses to beta-endorphin and morphine in rabbits.

Authors:  M T Lin; C Y Su
Journal:  J Physiol       Date:  1979-10       Impact factor: 5.182

Review 8.  Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.